Related Experiment Video
Updated: Apr 27, 2026

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis
Published on: June 15, 2011
Immune function of peripheral T cells in patients with venous thromboembolism or coronary artery atherosclerosis
Lin Zhou1, Haoming Song1, Wenjun Xu1
1Department of Cardiology, Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China.
Insights
Patients with venous thromboembolism (VTE) and coronary artery atherosclerosis (CAA) show reduced T cell function and elevated hs-CRP. These findings suggest immune and inflammatory mechanisms contribute to both arterial and venous thrombosis.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Hematology
Background:
- Arterial thrombotic diseases share risk factors with venous thromboembolism (VTE).
- T lymphocyte subsets (CD3, CD4, CD8) and CD4/CD8 ratio are crucial immune markers.
- High-sensitivity C-reactive protein (hs-CRP) is a marker of inflammation.
Purpose of the Study:
- To compare T lymphocyte expression (CD3, CD4, CD8), CD4/CD8 ratio, and hs-CRP levels in VTE patients, coronary artery atherosclerosis (CAA) patients, and healthy controls.
- To elucidate the role of immune and inflammatory factors in VTE and CAA.
Main Methods:
- Recruited 51 VTE patients, 114 CAA patients, and 82 healthy subjects.
- Measured T lymphocyte expression (CD3, CD4, CD8) and CD4/CD8 ratio.
- Quantified serum hs-CRP levels.
Main Results:
- VTE patients exhibited significantly reduced CD3 and CD8 expression and an increased CD4/CD8 ratio compared to healthy subjects.
- VTE and CAA patients showed comparable T lymphocyte profiles and higher hs-CRP levels than healthy controls.
- A higher proportion of VTE or CAA patients had reduced CD3+/CD8+ T cells or elevated CD4/CD8 ratios versus healthy subjects.
Conclusions:
- Patients with VTE or CAA have impaired T cell antigen recognition, signal transduction, and cytotoxic function.
- Inflammatory and immune mechanisms are implicated in the pathogenesis of both venous and arterial thrombosis.
Introduction And Objectives:
Recent studies have shown that the major risk factors for arterial thrombotic diseases are closely associated with venous thromboembolism (VTE). This study aimed to investigate the expression of CD3, CD4 and CD8 in T lymphocytes, the CD4/CD8 ratio and high-sensitivity C-reactive protein (hs-CRP) levels in patients with VTE, coronary artery atherosclerosis (CAA) and healthy subjects.
Methods:
A total of 82 healthy subjects, 51 VTE patients and 114 CAA patients were recruited, and the expression of CD3, CD4 and CD8 in T lymphocytes and the CD4/CD8 ratio were determined. Serum hs-CRP was also measured.
Results:
Compared to healthy subjects, VTE patients had significantly reduced CD3 expression (p=0.019), comparable CD4 expression (p=0.868), significantly reduced CD8 expression (p<0.001) and increased CD4/CD8 ratio (p=0.044). However, VTE patients had comparable expression of CD3, CD4 and CD8 and CD4/CD8 ratio to CAA patients. In addition, among patients with VTE or CAA, the proportion of patients with reduced CD3+ and CD8+ T lymphocytes or increased CD4/CD8 ratio was significantly higher than in healthy subjects. In addition, hs-CRP in both VTE and CAA groups was significantly higher than in healthy subjects.
Conclusions:
The antigen recognition and signal transduction activation of T cells is significantly reduced in patients with VTE or CAA, and the killing effect of T cells on pathogens, including viruses, is also significantly compromised. In addition, inflammatory and immune mechanisms are involved in the occurrence and development of venous and arterial thrombosis.
More Related Videos
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
04:30Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Anticoagulant Drugs: Low-Molecular-Weight Heparins
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...